Company intelligence / Profile preview

MSN Life Sciences

Hyderabad, Telangana, Indiamsnlabs.com ↗

Ownership: Private
Employees: ~2121
Development stage: Other

Overview

MSN Life Sciences is a core manufacturing and development division of the MSN Group, focusing on the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company has successfully launched numerous generic versions of complex molecules, including first-to-market launches in India for drugs like Tolvaptan and Ambrisentan. Their clinical results are primarily centered around bioequivalence studies for global regulatory approvals (ANDA/DMF).

Therapeutic areas: Women's HealthEndocrinologyCardiovascularNeurologyInfectious DiseasesPulmonologyRare DiseasesRheumatologyOncologyMen's Health
Modalities: Small moleculePeptidesHormone
Industry: Biotech

Partnerships

Zydus LifesciencesMega LifesciencesBreckenridge Pharmaceutical

Beyond the preview

Go deeper on MSN Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSN Life Sciences.